Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price traded up 4.5% on Tuesday . The company traded as high as $1.84 and last traded at $1.84. 162,971 shares were traded during trading, an increase of 143% from the average session volume of 67,097 shares. The stock had previously closed at $1.76.
Cardiol Therapeutics Trading Up 4.5 %
The business has a 50 day simple moving average of $1.67 and a two-hundred day simple moving average of $1.19.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
See Also
- Five stocks we like better than Cardiol Therapeutics
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Charles Schwab Fortifies its Uptrend on EPS Beat
- The Significance of Brokerage Rankings in Stock Selection
- Lockheed Martin Stock Aims for a Fresh All-Time High
- NYSE Stocks Give Investors a Variety of Quality Options
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
